Form EFFECT TITAN PHARMACEUTICALS
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | November 14, 2025 |
| Accession Number: | 0001829126-25-008007 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merifund Capital Management Backs Fed Bank Resilience
- As Stress, Burnout, and Digital Overload Shape Daily Life, "Doing Nothing" Can Help the Body and Mind Recover
- Global Power Solutions Announces Registration to Attend Data Centre West 2026 in Calgary and Applauds Meta’s Historic CAD $13 Billion Alberta Data Centre Investment
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
